Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-ALT plus FOLFOX4 as adjuvant therapy for stage III colon cancer
ChiCTR-TRC-08000135Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin + fluorouracil + leucovorin in colon cancer (2 arms), sponsored by Sun Yat-sen University. Primary endpoints: overall survival rate and disease-free survival. Started Mar 2008; status: completed.
02
Drugs
oxaliplatin + fluorouracil + leucovorin
03
Conditions
colon cancer
Beyond the preview
Go deeper on ChiCTR-TRC-08000135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000135.